{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:26:23Z","timestamp":1787239583222,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s42000-023-00494-y","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T03:01:40Z","timestamp":1696388500000},"page":"49-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Insulin-sensitizing agents for infertility treatment in woman with polycystic ovary syndrome: a narrative review of current clinical practice"],"prefix":"10.1007","volume":"23","author":[{"given":"Radmila","family":"Spari\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mladen","family":"Andji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Raki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelica","family":"Bjeki\u0107-Macut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarantis","family":"Livadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Konti\u0107-Vu\u010dini\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-8596","authenticated-orcid":false,"given":"Djuro","family":"Macut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"494_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"494_CR2","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-14-0253","volume":"171","author":"G Conway","year":"2014","unstructured":"Conway G, Dewailly D, Diamanti-Kandarakis E et al (2014) The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171:P1\u2013P29. https:\/\/doi.org\/10.1530\/EJE-14-0253","journal-title":"Eur J Endocrinol"},{"key":"494_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/03630242.2019.1587664","volume":"59","author":"D Stevanovic","year":"2019","unstructured":"Stevanovic D, Bozic-Antic I, Stanojlovic O et al (2019) Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): a psychometric study with the Serbian version. Women Health 59:1015\u20131025. https:\/\/doi.org\/10.1080\/03630242.2019.1587664","journal-title":"Women Health"},{"key":"494_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jsbmb.2018.04.008","volume":"182","author":"S Patel","year":"2018","unstructured":"Patel S (2018) Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol 182:27\u201336. https:\/\/doi.org\/10.1016\/j.jsbmb.2018.04.008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"494_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/humrep\/der418","volume":"27","author":"D Panidis","year":"2012","unstructured":"Panidis D, Tziomalos K, Misichronis G et al (2012) Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod 27:541\u2013549. https:\/\/doi.org\/10.1093\/humrep\/der418","journal-title":"Hum Reprod"},{"key":"494_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/cen.12008","volume":"78","author":"D Panidis","year":"2013","unstructured":"Panidis D, Macut D, Tziomalos K et al (2013) Prevalence of metabolic syndrome in women with polycystic ovary syndrome. Clin Endocrinol 78:586\u2013592. https:\/\/doi.org\/10.1111\/cen.12008","journal-title":"Clin Endocrinol"},{"key":"494_CR7","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/humrep\/dew076","volume":"31","author":"D Macut","year":"2016","unstructured":"Macut D, Tziomalos K, Bo\u017ei\u0107-Anti\u0107 I et al (2016) Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome. Hum Reprod 31:1347\u20131353. https:\/\/doi.org\/10.1093\/humrep\/dew076","journal-title":"Hum Reprod"},{"key":"494_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","volume":"130","author":"D Macut","year":"2017","unstructured":"Macut D, Bjeki\u0107-Macut J, Raheli\u0107 D, Dokni\u0107 M (2017) Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pract 130:163\u2013170. https:\/\/doi.org\/10.1016\/j.diabres.2017.06.011","journal-title":"Diabetes Res Clin Pract"},{"key":"494_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40618-021-01691-5","volume":"45","author":"V Soldat-Stankovi\u0107","year":"2022","unstructured":"Soldat-Stankovi\u0107 V, Popovi\u0107-Peji\u010di\u0107 S, Stankovi\u0107 S et al (2022) The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial. J Endocrinol Investig 45:583\u2013595. https:\/\/doi.org\/10.1007\/s40618-021-01691-5","journal-title":"J Endocrinol Investig"},{"key":"494_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.bpobgyn.2004.05.006","volume":"18","author":"R Homburg","year":"2004","unstructured":"Homburg R (2004) Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:773\u2013788. https:\/\/doi.org\/10.1016\/j.bpobgyn.2004.05.006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"494_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/bmj.39335.462303.80","volume":"335","author":"AH Balen","year":"2007","unstructured":"Balen AH, Rutherford AJ (2007) Managing anovulatory infertility and polycystic ovary syndrome. BMJ 335:663\u2013666. https:\/\/doi.org\/10.1136\/bmj.39335.462303.80","journal-title":"BMJ"},{"key":"494_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.22074\/ijfs.2020.5608","volume":"13","author":"MA Gadalla","year":"2020","unstructured":"Gadalla MA, Norman RJ, Tay CT et al (2020) Medical and surgical treatment of reproductive outcomes in polycystic ovary syndrome: an overview of systematic reviews. Int J Fertil Steril 13:257\u2013270. https:\/\/doi.org\/10.22074\/ijfs.2020.5608","journal-title":"Int J Fertil Steril"},{"key":"494_CR13","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrendo.2012.69","volume":"8","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E (2012) Infertility treatment in PCOS\u2014is metformin in from the cold? Nat Rev Endocrinol 8:328\u2013330. https:\/\/doi.org\/10.1038\/nrendo.2012.69","journal-title":"Nat Rev Endocrinol"},{"key":"494_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s42000-021-00289-z","volume":"20","author":"AP Tsiami","year":"2021","unstructured":"Tsiami AP, Goulis DG, Sotiriadis AI, Kolibianakis EM (2021) Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis. Hormones (Athens) 20:449\u2013461. https:\/\/doi.org\/10.1007\/s42000-021-00289-z","journal-title":"Hormones (Athens)"},{"key":"494_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40618-020-01351-0","volume":"44","author":"P Moghetti","year":"2021","unstructured":"Moghetti P, Tosi F (2021) Insulin resistance and PCOS: chicken or egg? J Endocrinol Investig 44:233\u2013244. https:\/\/doi.org\/10.1007\/s40618-020-01351-0","journal-title":"J Endocrinol Investig"},{"key":"494_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.14310\/horm.2002.11181","volume":"5","author":"R Fleming","year":"2006","unstructured":"Fleming R (2006) The use of insulin sensitising agents in ovulation induction in women with Polycystic Ovary Syndrome. Hormones (Athens) 5:171\u2013178. https:\/\/doi.org\/10.14310\/horm.2002.11181","journal-title":"Hormones (Athens)"},{"key":"494_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev.med.52.1.401","volume":"52","author":"A Dunaif","year":"2001","unstructured":"Dunaif A, Thomas A (2001) Current concepts in the polycystic ovary syndrome. Annu Rev Med 52:401\u2013419. https:\/\/doi.org\/10.1146\/annurev.med.52.1.401","journal-title":"Annu Rev Med"},{"key":"494_CR18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1210\/jc.2017-01958","volume":"103","author":"JY Kim","year":"2018","unstructured":"Kim JY, Tfayli H, Michaliszyn SF, Arslanian S (2018) Impaired lipolysis, diminished fat oxidation, and metabolic inflexibility in obese girls with polycystic ovary syndrome. J Clin Endocrinol Metab 103:546\u2013554. https:\/\/doi.org\/10.1210\/jc.2017-01958","journal-title":"J Clin Endocrinol Metab"},{"key":"494_CR19","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M et al (2021) Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci 22:3789. https:\/\/doi.org\/10.3390\/ijms22073789","journal-title":"Int J Mol Sci"},{"key":"494_CR20","doi-asserted-by":"publisher","first-page":"CD002249","DOI":"10.1002\/14651858.CD002249.pub4","volume":"4","author":"J Brown","year":"2009","unstructured":"Brown J, Farquhar C, Beck J et al (2009) Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev 4:CD002249. https:\/\/doi.org\/10.1002\/14651858.CD002249.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"494_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ando.2022.04.004","volume":"83","author":"C Vatier","year":"2022","unstructured":"Vatier C, Christin-Maitre S, Vigouroux C (2022) Role of insulin resistance on fertility \u2013 focus on polycystic ovary syndrome. Ann Endocrinol (Paris) 83:199\u2013202. https:\/\/doi.org\/10.1016\/j.ando.2022.04.004","journal-title":"Ann Endocrinol (Paris)"},{"key":"494_CR22","doi-asserted-by":"publisher","first-page":"657889","DOI":"10.3389\/fendo.2021.657889","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Li J, Yan Z et al (2021) Improvement of insulin sensitivity increases pregnancy rate in infertile PCOS women: a systemic review. Front Endocrinol (Lausanne) 12:657889","journal-title":"Front Endocrinol (Lausanne)"},{"key":"494_CR23","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","volume":"41","author":"A Dunaif","year":"1992","unstructured":"Dunaif A, Segal KR, Shelley DR et al (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257\u20131266. https:\/\/doi.org\/10.2337\/diab.41.10.1257","journal-title":"Diabetes"},{"key":"494_CR24","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98:2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017","journal-title":"Physiol Rev"},{"key":"494_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","volume":"12","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG (2006) Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 12:324\u2013332. https:\/\/doi.org\/10.1016\/j.molmed.2006.05.006","journal-title":"Trends Mol Med"},{"key":"494_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","volume":"79","author":"K Tremellen","year":"2012","unstructured":"Tremellen K, Pearce K (2012) Dysbiosis of gut microbiota (DOGMA) \u2013 a novel theory for the development of polycystic ovarian syndrome. Med Hypotheses 79:104\u2013112. https:\/\/doi.org\/10.1016\/j.mehy.2012.04.016","journal-title":"Med Hypotheses"},{"key":"494_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5468\/ogs.21185","volume":"65","author":"J Parker","year":"2022","unstructured":"Parker J, O\u2019Brien C, Hawrelak J (2022) A narrative review of the role of gastrointestinal dysbiosis in the pathogenesis of polycystic ovary syndrome. Obstet Gynecol Sci 65:14\u201328. https:\/\/doi.org\/10.5468\/ogs.21185","journal-title":"Obstet Gynecol Sci"},{"key":"494_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.fertnstert.2017.06.026","volume":"108","author":"A Penzias","year":"2017","unstructured":"Penzias A, Bendikson K, Butts S et al (2017) Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil Steril 108:426\u2013441. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.06.026","journal-title":"Fertil Steril"},{"key":"494_CR29","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/humrep\/dep466","volume":"25","author":"S Palomba","year":"2010","unstructured":"Palomba S, Falbo A, Russo T et al (2010) Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response. Hum Reprod 25:1005\u20131013. https:\/\/doi.org\/10.1093\/humrep\/dep466","journal-title":"Hum Reprod"},{"key":"494_CR30","doi-asserted-by":"publisher","first-page":"E1491","DOI":"10.1210\/jc.2013-1865","volume":"98","author":"S Rice","year":"2013","unstructured":"Rice S, Elia A, Jawad Z et al (2013) Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab 98:E1491\u2013E1500. https:\/\/doi.org\/10.1210\/jc.2013-1865","journal-title":"J Clin Endocrinol Metab"},{"key":"494_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12958-021-00772-7","volume":"19","author":"L Yuan","year":"2021","unstructured":"Yuan L, Wu H, Huang W et al (2021) The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis. Reprod Biol Endocrinol 19:89. https:\/\/doi.org\/10.1186\/s12958-021-00772-7","journal-title":"Reprod Biol Endocrinol"},{"key":"494_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/rmb2.12315","volume":"19","author":"S Nishihara","year":"2020","unstructured":"Nishihara S, Fukuda J, Ezoe K et al (2020) Does the endometrial thickness on the day of the trigger affect the pregnancy outcomes after fresh cleaved embryo transfer in the clomiphene citrate-based minimal stimulation cycle? Reprod Med Biol 19:151\u2013157. https:\/\/doi.org\/10.1002\/rmb2.12315","journal-title":"Reprod Med Biol"},{"key":"494_CR33","doi-asserted-by":"publisher","first-page":"e1419","DOI":"10.1210\/clinem\/dgz117","volume":"105","author":"RA Chi","year":"2020","unstructured":"Chi RA, Wang T, Adams N et al (2020) Human endometrial transcriptome and progesterone receptor cistrome reveal important pathways and epithelial regulators. J Clin Endocrinol Metab 105:e1419\u2013e1439. https:\/\/doi.org\/10.1210\/clinem\/dgz117","journal-title":"J Clin Endocrinol Metab"},{"key":"494_CR34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/molehr\/gaaa023","volume":"26","author":"M Hu","year":"2020","unstructured":"Hu M, Zhang Y, Li X et al (2020) Alterations of endometrial epithelial\u2013mesenchymal transition and MAPK signalling components in women with PCOS are partially modulated by metformin in vitro. Mol Hum Reprod 26:312\u2013326. https:\/\/doi.org\/10.1093\/molehr\/gaaa023","journal-title":"Mol Hum Reprod"},{"key":"494_CR35","doi-asserted-by":"publisher","first-page":"e1022","DOI":"10.1210\/clinem\/dgaa951","volume":"106","author":"M Hu","year":"2021","unstructured":"Hu M, Zhang Y, Li X et al (2021) TLR4-associated IRF-7 and NF\u03baB signaling act as a molecular link between androgen and metformin activities and cytokine synthesis in the PCOS endometrium. J Clin Endocrinol Metab 106:e1022\u2013e1040. https:\/\/doi.org\/10.1210\/clinem\/dgaa951","journal-title":"J Clin Endocrinol Metab"},{"key":"494_CR36","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1210\/er.2014-1045","volume":"35","author":"B Gellersen","year":"2014","unstructured":"Gellersen B, Brosens JJ (2014) Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev 35:851\u2013905. https:\/\/doi.org\/10.1210\/er.2014-1045","journal-title":"Endocr Rev"},{"key":"494_CR37","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.biopha.2018.10.128","volume":"109","author":"F Xiong","year":"2019","unstructured":"Xiong F, Xiao J, Bai Y et al (2019) Metformin inhibits estradiol and progesterone-induced decidualization of endometrial stromal cells by regulating expression of progesterone receptor, cytokines and matrix metalloproteinases. Biomed Pharmacother 109:1578\u20131585. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.128","journal-title":"Biomed Pharmacother"},{"key":"494_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/1933719114561552","volume":"22","author":"MMB Schulte","year":"2015","unstructured":"Schulte MMB, Tsai J, Moley KH (2015) Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation. Reprod Sci 22:6\u201314. https:\/\/doi.org\/10.1177\/1933719114561552","journal-title":"Reprod Sci"},{"key":"494_CR39","first-page":"574","volume":"7","author":"X Li","year":"2015","unstructured":"Li X, Cui P, Jiang H-Y et al (2015) Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action. Am J Transl Res 7:574\u2013586","journal-title":"Am J Transl Res"},{"key":"494_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1095\/biolreprod.112.099788","volume":"87","author":"J Zhai","year":"2012","unstructured":"Zhai J, Liu C, Tian Z et al (2012) Effects of metformin on the expression of GLUT4 in endometrium of obese women with polycystic ovary syndrome. Biol Reprod 87:29. https:\/\/doi.org\/10.1095\/biolreprod.112.099788","journal-title":"Biol Reprod"},{"key":"494_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12958-021-00765-6","volume":"19","author":"M Ohara","year":"2021","unstructured":"Ohara M, Yoshida-Komiya H, Ono-Okutsu M et al (2021) Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome. Reprod Biol Endocrinol 19:77. https:\/\/doi.org\/10.1186\/s12958-021-00765-6","journal-title":"Reprod Biol Endocrinol"},{"key":"494_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/09513590.2014.951321","volume":"31","author":"A Ito-Yamaguchi","year":"2015","unstructured":"Ito-Yamaguchi A, Suganuma R, Kumagami A et al (2015) Effects of metformin on endocrine, metabolic milieus and endometrial expression of androgen receptor in patients with polycystic ovary syndrome. Gynecol Endocrinol 31:44\u201347. https:\/\/doi.org\/10.3109\/09513590.2014.951321","journal-title":"Gynecol Endocrinol"},{"key":"494_CR43","doi-asserted-by":"publisher","first-page":"e1968450","DOI":"10.1155\/2018\/1968450","volume":"2018","author":"A Bevilacqua","year":"2018","unstructured":"Bevilacqua A, Bizzarri M (2018) Inositols in insulin signaling and glucose metabolism. Int J Endocrinol 2018:e1968450. https:\/\/doi.org\/10.1155\/2018\/1968450","journal-title":"Int J Endocrinol"},{"key":"494_CR44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.tem.2018.09.001","volume":"29","author":"AS Lagan\u00e0","year":"2018","unstructured":"Lagan\u00e0 AS, Garzon S, Casarin J et al (2018) Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends Endocrinol Metab 29:768\u2013780. https:\/\/doi.org\/10.1016\/j.tem.2018.09.001","journal-title":"Trends Endocrinol Metab"},{"key":"494_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/humupd\/dmy045","volume":"25","author":"J Pundir","year":"2019","unstructured":"Pundir J, Charles D, Sabatini L et al (2019) Overview of systematic reviews of non-pharmacological interventions in women with polycystic ovary syndrome. Hum Reprod Update 25:243\u2013256. https:\/\/doi.org\/10.1093\/humupd\/dmy045","journal-title":"Hum Reprod Update"},{"key":"494_CR46","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/0006-291X(87)90519-5","volume":"149","author":"AR Saltiel","year":"1987","unstructured":"Saltiel AR, Sorbara-Cazan LR (1987) Inositol glycan mimics the action of insulin on glucose utilization in rat adipocytes. Biochem Biophys Res Commun 149:1084\u20131092. https:\/\/doi.org\/10.1016\/0006-291X(87)90519-5","journal-title":"Biochem Biophys Res Commun"},{"key":"494_CR47","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.rbmo.2016.08.024","volume":"33","author":"AD Genazzani","year":"2016","unstructured":"Genazzani AD (2016) Inositol as putative integrative treatment for PCOS. Reprod BioMed Online 33:770\u2013780. https:\/\/doi.org\/10.1016\/j.rbmo.2016.08.024","journal-title":"Reprod BioMed Online"},{"key":"494_CR48","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/humrep\/17.6.1591","volume":"17","author":"TTY Chiu","year":"2002","unstructured":"Chiu TTY, Rogers MS, Law ELK et al (2002) Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod 17:1591\u20131596. https:\/\/doi.org\/10.1093\/humrep\/17.6.1591","journal-title":"Hum Reprod"},{"key":"494_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ijgo.13971","volume":"158","author":"G Kachhawa","year":"2022","unstructured":"Kachhawa G, Senthil Kumar KV, Kulshrestha V et al (2022) Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: a randomized open-label study. Int J Gynaecol Obstet 158:278\u2013284. https:\/\/doi.org\/10.1002\/ijgo.13971","journal-title":"Int J Gynaecol Obstet"},{"key":"494_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s43043-021-00085-0","volume":"26","author":"M Mitra\u0161inovi\u0107-Bruli\u0107","year":"2021","unstructured":"Mitra\u0161inovi\u0107-Bruli\u0107 M, Buljan M, Suljevi\u0107 D (2021) Association of LH\/FSH ratio with menstrual cycle regularity and clinical features of patients with polycystic ovary syndrome. Middle East Fertil Soc J 26:40. https:\/\/doi.org\/10.1186\/s43043-021-00085-0","journal-title":"Middle East Fertil Soc J"},{"key":"494_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12958-016-0189-2","volume":"14","author":"S Sacchi","year":"2016","unstructured":"Sacchi S, Marinaro F, Tondelli D et al (2016) Modulation of gonadotrophin induced steroidogenic enzymes in granulosa cells by d-chiroinositol. Reprod Biol Endocrinol 14:52. https:\/\/doi.org\/10.1186\/s12958-016-0189-2","journal-title":"Reprod Biol Endocrinol"},{"key":"494_CR52","doi-asserted-by":"publisher","first-page":"E237","DOI":"10.1152\/ajpendo.00162.2019","volume":"318","author":"H Cabrera-Cruz","year":"2020","unstructured":"Cabrera-Cruz H, Or\u00f3stica L, Plaza-Parrochia F et al (2020) The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment. Am J Physiol Endocrinol Metab 318:E237\u2013E248. https:\/\/doi.org\/10.1152\/ajpendo.00162.2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"494_CR53","doi-asserted-by":"publisher","first-page":"CD010564","DOI":"10.1002\/14651858.CD010564.pub2","volume":"7","author":"JM Dodd","year":"2018","unstructured":"Dodd JM, Grivell RM, Deussen AR, Hague WM (2018) Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes. Cochrane Database Syst Rev 7:CD010564. https:\/\/doi.org\/10.1002\/14651858.CD010564.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"494_CR54","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa063971","volume":"356","author":"RS Legro","year":"2007","unstructured":"Legro RS, Barnhart HX, Schlaff WD et al (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356:551\u2013566. https:\/\/doi.org\/10.1056\/NEJMoa063971","journal-title":"N Engl J Med"},{"key":"494_CR55","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/aogs.12673","volume":"94","author":"H Abu Hashim","year":"2015","unstructured":"Abu Hashim H, Foda O, Ghayaty E (2015) Combined metformin-clomiphene in clomiphene-resistant polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand 94:921\u2013930. https:\/\/doi.org\/10.1111\/aogs.12673","journal-title":"Acta Obstet Gynecol Scand"},{"key":"494_CR56","doi-asserted-by":"publisher","first-page":"CD003053","DOI":"10.1002\/14651858.CD003053.pub6","volume":"11","author":"LC Morley","year":"2017","unstructured":"Morley LC, Tang T, Yasmin E et al (2017) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 11:CD003053. https:\/\/doi.org\/10.1002\/14651858.CD003053.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"494_CR57","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jsps.2016.12.001","volume":"25","author":"YS Al-Ruthia","year":"2017","unstructured":"Al-Ruthia YS, Al-Mandeel H, AlSanawi H et al (2017) Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome. Saudi Pharm J 25:795\u2013800. https:\/\/doi.org\/10.1016\/j.jsps.2016.12.001","journal-title":"Saudi Pharm J"},{"key":"494_CR58","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1210\/jc.2011-3061","volume":"97","author":"L Morin-Papunen","year":"2012","unstructured":"Morin-Papunen L, Rantala AS, Unkila-Kallio L et al (2012) Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab 97:1492\u20131500. https:\/\/doi.org\/10.1210\/jc.2011-3061","journal-title":"J Clin Endocrinol Metab"},{"key":"494_CR59","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/j.1447-0756.2010.01507.x","volume":"37","author":"S Weerakiet","year":"2011","unstructured":"Weerakiet S, Sophonsritsuk A, Lertvikool S et al (2011) Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome. J Obstet Gynaecol Res 37:1229\u20131237. https:\/\/doi.org\/10.1111\/j.1447-0756.2010.01507.x","journal-title":"J Obstet Gynaecol Res"},{"key":"494_CR60","doi-asserted-by":"publisher","first-page":"CD013505","DOI":"10.1002\/14651858.CD013505","volume":"12","author":"A Sharpe","year":"2019","unstructured":"Sharpe A, Morley LC, Tang T et al (2019) Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst Rev 12:CD013505. https:\/\/doi.org\/10.1002\/14651858.CD013505","journal-title":"Cochrane Database Syst Rev"},{"key":"494_CR61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejogrb.2022.01.025","volume":"271","author":"R Magzoub","year":"2022","unstructured":"Magzoub R, Kheirelseid EAH, Perks C, Lewis S (2022) Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review. Eur J Obstet Gynecol Reprod Biol 271:38\u201362. https:\/\/doi.org\/10.1016\/j.ejogrb.2022.01.025","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"494_CR62","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/09513590701672405","volume":"23","author":"E Papaleo","year":"2007","unstructured":"Papaleo E, Unfer V, Baillargeon J-P et al (2007) Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol 23:700\u2013703. https:\/\/doi.org\/10.1080\/09513590701672405","journal-title":"Gynecol Endocrinol"},{"key":"494_CR63","doi-asserted-by":"publisher","unstructured":"Regidor P-A, Schindler AE, Lesoine B, Druckman R (2018) Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Horm Mol Biol Clin Invest 34. https:\/\/doi.org\/10.1515\/hmbci-2017-0067","DOI":"10.1515\/hmbci-2017-0067"},{"key":"494_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12958-023-01055-z","volume":"21","author":"D Greff","year":"2023","unstructured":"Greff D, Juh\u00e1sz AE, V\u00e1ncsa S et al (2023) Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol 21:10. https:\/\/doi.org\/10.1186\/s12958-023-01055-z","journal-title":"Reprod Biol Endocrinol"},{"key":"494_CR65","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.26355\/eurrev_201906_18223","volume":"23","author":"M Nordio","year":"2019","unstructured":"Nordio M, Basciani S, Camajani E (2019) The 40:1 myo-inositol\/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci 23:5512\u20135521. https:\/\/doi.org\/10.26355\/eurrev_201906_18223","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"494_CR66","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00404-019-05064-5","volume":"299","author":"S Pourghasem","year":"2019","unstructured":"Pourghasem S, Bazarganipour F, Taghavi SA, Kutenaee MA (2019) The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole. Arch Gynecol Obstet 299:1193\u20131199. https:\/\/doi.org\/10.1007\/s00404-019-05064-5","journal-title":"Arch Gynecol Obstet"},{"key":"494_CR67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1479164118825376","volume":"16","author":"RA DeFronzo","year":"2019","unstructured":"DeFronzo RA, Inzucchi S, Abdul-Ghani M, Nissen SE (2019) Pioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes. Diab Vasc Dis Res 16:133\u2013143. https:\/\/doi.org\/10.1177\/1479164118825376","journal-title":"Diab Vasc Dis Res"},{"key":"494_CR68","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1093\/humrep\/deg343","volume":"18","author":"CJ Glueck","year":"2003","unstructured":"Glueck CJ, Moreira A, Goldenberg N et al (2003) Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin. Hum Reprod 18:1618\u20131625. https:\/\/doi.org\/10.1093\/humrep\/deg343","journal-title":"Hum Reprod"},{"key":"494_CR69","doi-asserted-by":"publisher","first-page":"293","DOI":"10.22074\/ijfs.2019.5471","volume":"12","author":"ZS Hosseiny","year":"2019","unstructured":"Hosseiny ZS, Nikpour P, Bakhtiary A et al (2019) Evaluation of osteopontin gene expression in endometrium of diabetic rat models treated with metformin and pioglitazone. Int J Fertil Steril 12:293\u2013297. https:\/\/doi.org\/10.22074\/ijfs.2019.5471","journal-title":"Int J Fertil Steril"},{"key":"494_CR70","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1210\/jcem.86.10.7906","volume":"86","author":"KBC Apparao","year":"2001","unstructured":"Apparao KBC, Murray MJ, Fritz MA et al (2001) Osteopontin and its receptor \u03b1v\u03b23 integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab 86:4991\u20135000. https:\/\/doi.org\/10.1210\/jcem.86.10.7906","journal-title":"J Clin Endocrinol Metab"},{"key":"494_CR71","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jpag.2014.01.104","volume":"27","author":"M Pawelczak","year":"2014","unstructured":"Pawelczak M, Rosenthal J, Milla S et al (2014) Evaluation of the pro-inflammatory cytokine tumor necrosis factor-\u03b1 in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 27:356\u2013359. https:\/\/doi.org\/10.1016\/j.jpag.2014.01.104","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"494_CR72","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00109-020-01985-w","volume":"98","author":"R Paravati","year":"2020","unstructured":"Paravati R, De Mello N, Onyido EK et al (2020) Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients. J Mol Med 98:1713\u20131725. https:\/\/doi.org\/10.1007\/s00109-020-01985-w","journal-title":"J Mol Med"},{"key":"494_CR73","doi-asserted-by":"publisher","first-page":"16767","DOI":"10.1074\/jbc.M100040200","volume":"276","author":"W Arlt","year":"2001","unstructured":"Arlt W, Auchus RJ, Miller WL (2001) Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3\u03b2-hydroxysteroid dehydrogenase. J Biol Chem 276:16767\u201316771. https:\/\/doi.org\/10.1074\/jbc.M100040200","journal-title":"J Biol Chem"},{"key":"494_CR74","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1210\/jc.2003-031737","volume":"89","author":"N Brettenthaler","year":"2004","unstructured":"Brettenthaler N, De Geyter C, Huber PR, Keller U (2004) Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:3835\u20133840. https:\/\/doi.org\/10.1210\/jc.2003-031737","journal-title":"J Clin Endocrinol Metab"},{"key":"494_CR75","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00404-017-4480-z","volume":"296","author":"Y Xu","year":"2017","unstructured":"Xu Y, Wu Y, Huang Q (2017) Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis. Arch Gynecol Obstet 296:661\u2013677. https:\/\/doi.org\/10.1007\/s00404-017-4480-z","journal-title":"Arch Gynecol Obstet"},{"key":"494_CR76","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/humrep\/dem035","volume":"22","author":"CH Ramlau-Hansen","year":"2007","unstructured":"Ramlau-Hansen CH, Thulstrup AM, Nohr EA et al (2007) Subfecundity in overweight and obese couples. Hum Reprod 22:1634\u20131637. https:\/\/doi.org\/10.1093\/humrep\/dem035","journal-title":"Hum Reprod"},{"key":"494_CR77","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/humrep\/dem371","volume":"23","author":"JW van der Steeg","year":"2008","unstructured":"van der Steeg JW, Steures P, Eijkemans MJC et al (2008) Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod 23:324\u2013328. https:\/\/doi.org\/10.1093\/humrep\/dem371","journal-title":"Hum Reprod"},{"key":"494_CR78","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, Bozdag G, Yapici Z et al (2012) Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod 27:3067\u20133073. https:\/\/doi.org\/10.1093\/humrep\/des232","journal-title":"Hum Reprod"},{"key":"494_CR79","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/cphy.c180044","volume-title":"Comprehensive physiology","author":"G Grandl","year":"2019","unstructured":"Grandl G, Novikoff A, DiMarchi R et al (2019) Gut peptide agonism in the treatment of obesity and diabetes. In: Comprehensive physiology. John Wiley & Sons, Ltd, pp 99\u2013124"},{"key":"494_CR80","doi-asserted-by":"publisher","first-page":"170233","DOI":"10.1016\/j.peptides.2019.170233","volume":"125","author":"RC Moffett","year":"2020","unstructured":"Moffett RC, Naughton V (2020) Emerging role of GIP and related gut hormones in fertility and PCOS. Peptides 125:170233. https:\/\/doi.org\/10.1016\/j.peptides.2019.170233","journal-title":"Peptides"},{"key":"494_CR81","doi-asserted-by":"publisher","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","volume":"105","author":"H Cena","year":"2020","unstructured":"Cena H, Chiovato L, Nappi RE (2020) Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists. J Clin Endocrinol Metab 105:e2695\u2013e2709. https:\/\/doi.org\/10.1210\/clinem\/dgaa285","journal-title":"J Clin Endocrinol Metab"},{"key":"494_CR82","doi-asserted-by":"publisher","first-page":"204201882198923","DOI":"10.1177\/2042018821989238","volume":"12","author":"MA Abdalla","year":"2021","unstructured":"Abdalla MA, Deshmukh H, Atkin S, Sathyapalan T (2021) The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence. Ther Adv Endocrinol Metab 12:2042018821989238. https:\/\/doi.org\/10.1177\/2042018821989238","journal-title":"Ther Adv Endocrinol Metab"},{"key":"494_CR83","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.3390\/ijms23084334","volume":"23","author":"K Bednarz","year":"2022","unstructured":"Bednarz K, Kowalczyk K, Cwynar M et al (2022) The role of Glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome. Int J Mol Sci 23:4334. https:\/\/doi.org\/10.3390\/ijms23084334","journal-title":"Int J Mol Sci"},{"key":"494_CR84","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.rbmo.2017.03.023","volume":"35","author":"M Nylander","year":"2017","unstructured":"Nylander M, Fr\u00f8ssing S, Clausen HV et al (2017) Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial. Reprod BioMed Online 35:121\u2013127. https:\/\/doi.org\/10.1016\/j.rbmo.2017.03.023","journal-title":"Reprod BioMed Online"},{"key":"494_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-18-0175","volume":"179","author":"V Salamun","year":"2018","unstructured":"Salamun V, Jensterle M, Janez A, Vrtacnik Bokal E (2018) Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. Eur J Endocrinol 179:1\u201311. https:\/\/doi.org\/10.1530\/EJE-18-0175","journal-title":"Eur J Endocrinol"},{"key":"494_CR86","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s40618-023-02084-6","volume":"46","author":"G Pugliese","year":"2023","unstructured":"Pugliese G, de Alteriis G, Muscogiuri G et al (2023) Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? J Endocrinol Investig 46:1761\u20131774. https:\/\/doi.org\/10.1007\/s40618-023-02084-6","journal-title":"J Endocrinol Investig"},{"key":"494_CR87","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/cen.13454","volume":"87","author":"X Liu","year":"2017","unstructured":"Liu X, Zhang Y, Zheng S et al (2017) Efficacy of exenatide on weight loss, metabolic parameters and pregnancy in overweight\/obese polycystic ovary syndrome. Clin Endocrinol 87:767\u2013774. https:\/\/doi.org\/10.1111\/cen.13454","journal-title":"Clin Endocrinol"},{"key":"494_CR88","doi-asserted-by":"publisher","first-page":"106984","DOI":"10.1016\/j.ntt.2021.106984","volume":"87","author":"DL Graham","year":"2021","unstructured":"Graham DL, Madkour HS, Noble BL et al (2021) Long-term functional alterations following prenatal GLP-1R activation. Neurotoxicol Teratol 87:106984. https:\/\/doi.org\/10.1016\/j.ntt.2021.106984","journal-title":"Neurotoxicol Teratol"},{"key":"494_CR89","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s13669-023-00350-1","volume":"12","author":"A Nuako","year":"2023","unstructured":"Nuako A, Tu L, Campoverde Reyes KJ et al (2023) Pharmacologic treatment of obesity in reproductive aged women. Curr Obstet Gynecol Rep 12:138\u2013146. https:\/\/doi.org\/10.1007\/s13669-023-00350-1","journal-title":"Curr Obstet Gynecol Rep"},{"key":"494_CR90","doi-asserted-by":"publisher","first-page":"154908","DOI":"10.1016\/j.metabol.2021.154908","volume":"125","author":"V Kaur","year":"2021","unstructured":"Kaur V, Dimitriadis GK, P\u00e9rez-Pevida B et al (2021) Mechanisms of action of duodenal mucosal resurfacing in insulin resistant women with polycystic ovary syndrome. Metabolism 125:154908. https:\/\/doi.org\/10.1016\/j.metabol.2021.154908","journal-title":"Metabolism"},{"key":"494_CR91","doi-asserted-by":"publisher","first-page":"e10811","DOI":"10.7759\/cureus.10811","volume":"12","author":"R Lee","year":"2020","unstructured":"Lee R, Mathew CJ, Jose MT et al (2020) A review of the impact of bariatric surgery in women with polycystic ovary syndrome. Cureus 12:e10811. https:\/\/doi.org\/10.7759\/cureus.10811","journal-title":"Cureus"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00494-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-023-00494-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-023-00494-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T23:50:47Z","timestamp":1707263447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-023-00494-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1007\/s42000-023-00494-y","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"2 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was deemed unnecessary for this review study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable as this study is a review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}